Newsroom

PROSOLV CARDIOVASCULAR ENHANCES ITS ULTRASOUND IMAGE REVIEW AND REPORTING CAPABILITIES WITH PHILIPS QLAB INTERFACE

Will increase efficiencies for clinicians and enhance accuracy

Indianapolis, IN - April 24, 2008 - ProSolv CardioVascular, a FUJIFILM company is pleased to announce that it is the first third party cardiovascular image and information system (CVIIS) vendor that provides an interface to QLAB, proprietary ultrasound software from Philips. Facilities using Philips ultrasound systems will now benefit from the availability of Philips’ QLAB advanced 2D and 3D ultrasound quantification tools within the ProSolv® CardioVascular application, delivering efficiency benefits for clinicians and enhancing the accuracy of diagnosis.

“With the ProSolv-QLAB integration we still get all the diagnostic benefits and full functionality of the QLAB software that we previously had, but now with countless workflow and patient care benefits,” said Dr. Jim Swan, Cardiologist with Rouge Valley Cardiology, Toronto. “We’re thrilled to be one of the initial sites to be working with ProSolv CardioVascular and Philips and benefiting from this integration. From our experience and positive results, I think it’s safe to say that there will be tremendous demand from other customers for this type of integration,” said Dr. Swan.

“We are committed to supporting interoperability with other vendors, and ProSolv CardioVascular’s interface to our QLAB ultrasound application is a manifestation of our connected workflow strategy,” said Neal Grotenhuis, product manager, Cardiology Ultrasound IT, for Philips Healthcare. “We recognize that not all customers will have a single vendor lab and are more likely to choose equipment from vendors who work with each other to improve connected workflow. Having a customer-focused approach and a cooperative strategy with other vendors allows clinicians to choose equipment that best meets their needs based on clinical features, value and workflow.”

The ProSolv-QLAB interface allows the user to launch the QLAB application directly from the image while within the ProSolv CardioVascular application performing image review and reporting. This capability creates efficiencies during the diagnostic cycle by eliminating the need to perform the quantification on the ultrasound system after the images are acquired; it also eliminates the need to send the images to a stand-alone laptop or workstation for quantification. In addition to benefiting from this enhanced workflow, facilities also benefit from the potential to increase throughput of their ultrasound systems. With the ProSolv-QLAB interface it is possible to increase the number of patient exams because the ultrasound systems are no longer occupied with the advanced QLAB analysis.

In addition to workflow efficiencies, the ProSolv-QLAB interface will also reduce the potential for manual data entry errors. Images and data that are generated from the QLAB analysis can be seamlessly exported directly into the ProSolv CardioVascular database and clinical report to complete the clinical record. Without this interface and automatic transfer the data must be hand entered which is a potential cause of error. This feature further validates ProSolv CardioVascular’s leading reporting capabilities.

The interface of QLAB version 6.0 and ProSolv CardioVascular will be available in July 2008.

About ProSolv CardioVascular, a FUJIFILM Company
Founded in 1989 as Problem Solving Concepts, Inc. (“ProSolv”) and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solutions for the clinical analysis and management of digital medical images for cardiology. ProSolv CardioVascular’s software solutions consist of advanced reporting and image management software, comprehensive support services and third-party components. The ProSolv® CardioVascular Enterprise Image and Information Management solution improves physician productivity, enhances customer revenue opportunities, automates complex medical imaging workflow, and maximizes customers’ return on investment in capital equipment and clinical information systems. The company is headquartered in Indianapolis, Indiana. For more information visit http://www.prosolv.com.